Articles
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation
Goodman SG, Steg PG, Szarek M, et al.
Journal:
Eur Heart J Cardiovasc Pharmacother
First published: April 24, 2024 DOI: 10.1093/ehjcvp/pvae025
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmGoodman SG, Steg PG, Szarek M, et al.
Eur Heart J Cardiovasc Pharmacother
First published: April 24, 2024 DOI: 10.1093/ehjcvp/pvae025